Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Salloway

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Disease-modifying therapies in Alzheimer's diseaseStephen Salloway, Jacobo Mintzer, Myron F Weiner, et al.
The Clinical Neuropsychologist|June 1, 2004
Assessing visuoconstructional performance in AD, MCI and normal elderly using the Beery Visual-Motor Integration TestPaul Malloy, Heather Belanger, Stuart Hall, et al.
Current Alzheimer Research|August 22, 2018
Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension StudyStephen Salloway, Gad A Marshall, Ming Lu, et al.
Alzheimer'S Research & Therapy|June 25, 2018
Infrequent false positive [<sup>18</sup>F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaquesMilos D Ikonomovic, Enrico R Fantoni, Gill Farrar, et al.
Frontiers in Aging Neuroscience|November 26, 2020
Machine Learning Classification Identifies Cerebellar Contributions to Early and Moderate Cognitive Decline in Alzheimer's DiseaseMuriel M K Bruchhage, Stephen Correia, Paul Malloy, et al.
Alzheimer Disease and Associated Disorders|December 7, 2002
Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer diseaseSusan Rymer, Stephen Salloway, Lauren Norton, et al.
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Clinical Chemistry|May 28, 2015
Biomarkers, assays, and therapies for Alzheimer diseaseDaniel R Beriault, Eleftherios P Diamandis, Erik Portelius, et al.
Journal of the American Geriatrics Society|April 8, 2010
Evidence for the validity of the American Medical Association's caregiver self-assessment questionnaire as a screening measure for depressionGary Epstein-Lubow, Brandon A Gaudiano, Matthew Hinckley, et al.
Journal of Alzheimer'S Disease : JAD|April 20, 2011
Glial vascular degeneration in CADASILThea Brennan-Krohn, Stephen Salloway, Stephen Correia, et al.
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Disease-modifying therapies in Alzheimer's diseaseStephen Salloway, Jacobo Mintzer, Myron F Weiner, et al.
The Clinical Neuropsychologist|June 1, 2004
Assessing visuoconstructional performance in AD, MCI and normal elderly using the Beery Visual-Motor Integration TestPaul Malloy, Heather Belanger, Stuart Hall, et al.
Current Alzheimer Research|August 22, 2018
Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension StudyStephen Salloway, Gad A Marshall, Ming Lu, et al.
Alzheimer'S Research & Therapy|June 25, 2018
Infrequent false positive [<sup>18</sup>F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaquesMilos D Ikonomovic, Enrico R Fantoni, Gill Farrar, et al.
Frontiers in Aging Neuroscience|November 26, 2020
Machine Learning Classification Identifies Cerebellar Contributions to Early and Moderate Cognitive Decline in Alzheimer's DiseaseMuriel M K Bruchhage, Stephen Correia, Paul Malloy, et al.
Alzheimer Disease and Associated Disorders|December 7, 2002
Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer diseaseSusan Rymer, Stephen Salloway, Lauren Norton, et al.
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Clinical Chemistry|May 28, 2015
Biomarkers, assays, and therapies for Alzheimer diseaseDaniel R Beriault, Eleftherios P Diamandis, Erik Portelius, et al.
Journal of the American Geriatrics Society|April 8, 2010
Evidence for the validity of the American Medical Association's caregiver self-assessment questionnaire as a screening measure for depressionGary Epstein-Lubow, Brandon A Gaudiano, Matthew Hinckley, et al.
Journal of Alzheimer'S Disease : JAD|April 20, 2011
Glial vascular degeneration in CADASILThea Brennan-Krohn, Stephen Salloway, Stephen Correia, et al.
Pageof 20